DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc.
TypeSubsidiary
IndustryPharmaceuticals
Founded1991 (1991)
FounderD. Geoffrey Shulman
Defunct2012 (2012)
FateAcquired by Sun Pharmaceutical
SuccessorDUSA Dermatology
Headquarters,
United States
Area served
United States
ProductsDermatological pharmaceuticals and treatments
OwnerSun Pharmaceutical
Websitewww.dusapharma.com

DUSA Pharmaceuticals, Inc. was an American pharmaceutical company specializing in dermatological products and treatments. It was founded in 1991 by Canadian dermatologist and pharmaceutical executive D. Geoffrey Shulman, who served as the company's chairman, president and chief executive officer.

The company developed Levulan photodynamic therapy, a treatment using aminolevulinic acid. In 1999, Levulan became the first topical photodynamic therapy approved in the United States for the treatment of actinic keratosis. DUSA's products also included Nicomide.

DUSA was acquired by Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharmaceutical, in 2012. Its products continued to be marketed under the DUSA Dermatology name.